https://www.selleckchem.com/pr....oducts/bms-986020.ht
s (30%) experienced late toxicity, with only 1 grade 3 toxicity. This prospective study confirms that RT for MALT lymphoma provides excellent long-term RFS with acceptable rates of toxicity. Current efforts are focused on RT de-escalation in an effort to further avoid treatment-related morbidity. CLINICALTRIALS.GOV NCT04465162. This prospective study confirms that RT for MALT lymphoma provides excellent long-term RFS with acceptable rates of toxicity. Current efforts are focused on RT de-escalation in an effort to further avoid treat
Like
Comment
Share
